These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2126624)

  • 1. Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.
    Ravic M; Johnston A; Turner P
    Postgrad Med J; 1990; 66 Suppl 4():S30-4. PubMed ID: 2126624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants.
    Kohl C; Steinkellner M
    Drug Metab Dispos; 2000 Feb; 28(2):161-8. PubMed ID: 10640513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and gastrointestinal tolerability of lornoxicam, and effects on haemostasis and hepatic microsomal oxidation.
    Warrington SJ; Lewis Y; Dawnay A; Johnston A; Kovacs IB; Lamb E; Ravic M
    Postgrad Med J; 1990; 66 Suppl 4():S35-40. PubMed ID: 2284219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
    Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
    J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
    Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
    Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the interaction between lornoxicam and warfarin in healthy volunteers.
    Ravic M; Johnston A; Turner P; Ferber HP
    Hum Exp Toxicol; 1990 Nov; 9(6):413-4. PubMed ID: 2271233
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam.
    Pruss TP; Stroissnig H; Radhofer-Welte S; Wendtlandt W; Mehdi N; Takacs F; Fellier H
    Postgrad Med J; 1990; 66 Suppl 4():S18-21. PubMed ID: 2284216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lornoxicam in man.
    Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
    Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of chlortenoxicam and indomethacin on frusemide-induced diuresis.
    Hitoglou-Makedou A; Lawson M; Turner P; Ferber HP
    Postgrad Med J; 1989 Nov; 65(769):821-3. PubMed ID: 2694142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lornoxicam on serum pepsinogen levels.
    Kullich W; Klein G; Pöllmann G
    Postgrad Med J; 1990; 66 Suppl 4():S46-8. PubMed ID: 2149454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
    Skjodt NM; Davies NM
    Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5'-hydroxylation.
    Iida I; Miyata A; Arai M; Hirota M; Akimoto M; Higuchi S; Kobayashi K; Chiba K
    Drug Metab Dispos; 2004 Jan; 32(1):7-9. PubMed ID: 14709614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lornoxicam efficacy in acute pain (LEAP) trial.
    Sharma A; Pingle A; Baliga VP
    J Indian Med Assoc; 2008 Dec; 106(12):811-3. PubMed ID: 19370957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of cytochrome P450 CYP2C9 variant allele CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam in Chinese subjects].
    Zhang YF; Chen XY; Guo YJ; Si DY; Zhou H; Zhong DF
    Yao Xue Xue Bao; 2005 Sep; 40(9):796-9. PubMed ID: 16342679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No clinically relevant effect of lornoxicam intake on acenocoumarol pharmacokinetics and pharmacodynamics.
    Masche UP; Rentsch KM; von Felten A; Meier PJ; Fattinger KE
    Eur J Clin Pharmacol; 1999 Jan; 54(11):865-8. PubMed ID: 10027662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lornoxicam : pharmacology and usefulness to treat acute postoperative and musculoskeletal pain a narrative review.
    Hillstrom C; Jakobsson JG
    Expert Opin Pharmacother; 2013 Aug; 14(12):1679-94. PubMed ID: 23713572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetic studies with lornoxicam.
    Turner P; Johnston A
    Postgrad Med J; 1990; 66 Suppl 4():S28-9. PubMed ID: 2284218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of locally administered lornoxicam in the management of low back pain after lumbar epidural anesthesia: a double-blind, randomized, controlled study.
    Muslu B; Usta B; Muslu S; Yeşilay A; Gözdemir M; Sert H; Demircioglu R
    Minerva Anestesiol; 2009 Sep; 75(9):494-7. PubMed ID: 19461565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parecoxib vs. lornoxicam in the treatment of postoperative pain after laparoscopic cholecystectomy: a prospective randomized placebo-controlled trial.
    Papadima A; Lagoudianakis EE; Antonakis PT; Pattas M; Kremastinou F; Katergiannakis V; Manouras A; Georgiou L
    Eur J Anaesthesiol; 2007 Feb; 24(2):154-8. PubMed ID: 16938157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers.
    Ravic M; Johnston A; Turner P; Takacs F; Rosenow DE
    Hum Exp Toxicol; 1991 Sep; 10(5):375-7. PubMed ID: 1683552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.